Overall and inter‐individual effect of four different drug classes on soluble urokinase plasminogen activator receptor in type 1 and type 2 diabetes.

MLA

Rotbain Curovic, Viktor, et al. “Overall and Inter‐individual Effect of Four Different Drug Classes on Soluble Urokinase Plasminogen Activator Receptor in Type 1 and Type 2 Diabetes.” Diabetes, Obesity & Metabolism, vol. 25, no. 11, Nov. 2023, pp. 3152–60. EBSCOhost, https://doi.org/10.1111/dom.15209.

APA

Rotbain Curovic, V., Houlind, M. B., Kroonen, M. Y. A. M., Jongs, N., Zobel, E. H., Hansen, T. W., Tavenier, J., Eugen, O. J., Laverman, G. D., Kooy, A., Persson, F., Rossing, P., & Heerspink, H. J. L. (2023). Overall and inter‐individual effect of four different drug classes on soluble urokinase plasminogen activator receptor in type 1 and type 2 diabetes. Diabetes, Obesity & Metabolism, 25(11), 3152–3160. https://doi.org/10.1111/dom.15209

Chicago

Rotbain Curovic, Viktor, Morten B. Houlind, Marjolein Y. A. M. Kroonen, Niels Jongs, Emilie H. Zobel, Tine W. Hansen, Juliette Tavenier, et al. 2023. “Overall and Inter‐individual Effect of Four Different Drug Classes on Soluble Urokinase Plasminogen Activator Receptor in Type 1 and Type 2 Diabetes.” Diabetes, Obesity & Metabolism 25 (11): 3152–60. doi:10.1111/dom.15209.